Search results
...Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market - Regeneron ...
Benzinga· 3 days agoAnalyst projects Regeneron's Dupixent to drive COPD sales surge, envisioning $20B market by 2026 on larger addressable market.
Market Today: Boeing Delays 737 Production, Pfizer Extends Losse
Guru Focus· 1 day agoMarket Performance Overview The S&P 500 and Nasdaq Composite hit fresh record highs this week,...